产品
编 号：F412821
分子式：C12H19ClN2O7S2
分子量：402.87
分子式：C12H19ClN2O7S2
分子量：402.87
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
结构图
CAS No: 635318-26-2
产品详情
生物活性：
Pomaglumetad methionil hydrochloride (LY2140023 hydrochloride) is an orally active, methionine prodrug of the selective mGlu2/3 receptor agonist LY404039. Pomaglumetad methionil hydrochloride has the potential for schizophrenia research.
体内研究：
Pomaglumetad methionil (LY2140023; orally; 3-300 mg/kg; once daily for 7 days) dose-dependent increases the levels of the dopamine metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) .Animal Model:Male Fischer rats (approximately 250 g)
Dosage:3 mg/kg, 10 mg/kg, and 300 mg/kg
Administration:Orally; once daily for 7 days
Result:Dose-dependent increased the levels of the dopamine metabolites DOPAC and HVA.
体外研究：
Pomaglumetad methionil (LY2140023) is a high-affinity peptide transporter 1 (PEPT1) substrate with a Km value of ~30 μM.LY2140023 is active against [14C]Gly-Sar with an IC50 value of 0.018 mM.
Pomaglumetad methionil hydrochloride (LY2140023 hydrochloride) is an orally active, methionine prodrug of the selective mGlu2/3 receptor agonist LY404039. Pomaglumetad methionil hydrochloride has the potential for schizophrenia research.
体内研究：
Pomaglumetad methionil (LY2140023; orally; 3-300 mg/kg; once daily for 7 days) dose-dependent increases the levels of the dopamine metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) .Animal Model:Male Fischer rats (approximately 250 g)
Dosage:3 mg/kg, 10 mg/kg, and 300 mg/kg
Administration:Orally; once daily for 7 days
Result:Dose-dependent increased the levels of the dopamine metabolites DOPAC and HVA.
体外研究：
Pomaglumetad methionil (LY2140023) is a high-affinity peptide transporter 1 (PEPT1) substrate with a Km value of ~30 μM.LY2140023 is active against [14C]Gly-Sar with an IC50 value of 0.018 mM.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备